Skip to Content
Søg Menu

Demet Özcan

Breast Cancer: The Prognostic Value of Tumor-Infiltrating Lymphocytes

/ Demet Özcan
SABCS24Brystcancer Play the Video 06:43

Bivirkninger ved behandling af metastatisk blærecancer med EV+pembrolizumab

/ Jan Andreasen / Andreas Carus
Blærecancer
Hans Lassmann

The Role of Neuropathology in Advancing Understanding of Multiple Sclerosis

/ Hans Lassmann
MS Play the Video 12:54
Gerrit Slooter

Prehabilitation: Making Cancer Patients Fit for Surgery and Speeding Recovery

/ Gerrit Slooter
Onkologisk Forum 2024 Play the Video 03:30
Tarec El-galaly

Ingen ændringer i behandlingen inden for lymfom efter ASH 2024, men mange vigtige updates

/ Tarec Christoffer El-Galaly
ASH24Lymfom Play the Video 02:53
Hans Beier Ommen

ASH 2024: Nyt om AML i dansk perspektiv

/ Hans Beier Ommen
ASH24AML Play the Video 09:10
Interview With Thomas Powles

Maximizing the Tolerability of Enfortumab Vedotin + Pembrolizumab – The Upcoming New Standard Treatment for Advanced Bladder Cancer

/ Thomas Powles
Blærecancer Play the Video 05:55
Andreas Carus

Håndtering af bivirkninger ved førstelinjebehandling af urotelialcancer med enfortumab vedotin i kombination med pembrolizumab

/ Andreas Carus
Cancer Play the Video 06:52
Hope Rugo

Abemaciclib Shows Significant Benefit for HR-Positive HER2-Negative Patients with Advanced Breast Cancer

/ Hope S. Rugo
Brystcancer Play the Video 11:57
Emelie Hamotal Curovic Rotbain

Dansk Aften ASH 2024: Nye fremskridt i behandling af CLL

/ Emelie Hamotal Curovic Rotbain
ASH24CLL Play the Video 03:30
Back to top